Dogwood Therapeutics, Inc. (DWTX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Between 2026-08-02 and 2026-10-31, public records show 1 signal for Dogwood Therapeutics, Inc.. Most notable: 2026-10-19: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-10-31 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-10-26 | Sealbond Ltd; Conjoint Inc.; CK Life Sciences Intl (Holdings) Inc | director | A | 4,098,360 | 1.22 | $4,999,999 |
| 2025-11-21 | Conjoint Inc. | director | C | 2,842,638 | — | — |
| 2025-11-21 | Conjoint Inc. | director | C | 21,610,950 | — | — |
| 2025-11-21 | Sealbond Ltd; Conjoint Inc.; CK Life Sciences Intl (Holdings) Inc | director | C | 21,610,950 | — | — |
| 2025-11-21 | Sealbond Ltd; Conjoint Inc.; CK Life Sciences Intl (Holdings) Inc | director | C | 2,842,638 | — | — |
| 2023-08-21 | Pridgen William | director | P | 15,335 | 1.3 | $19,992 |
| 2023-08-17 | Duncan Gregory Scott | director | P | 25,000 | 1.25 | $31,245 |
| 2022-12-08 | Whitley Richard James | director | S | 1,800 | 0.26 | $466 |
| 2022-05-23 | Walsh Angela | officer | P | 2,000 | 4.58 | $9,150 |
| 2022-05-23 | Duncan Gregory Scott | director | P | 7,500 | 4.52 | $33,900 |
| 2022-05-18 | Whitley Richard James | director | P | 500 | 4.53 | $2,263 |
| 2022-05-18 | Pridgen William | director | P | 241 | 4.5 | $1,085 |
| 2022-05-17 | Pridgen William | director | P | 13,450 | 4.38 | $58,914 |
| 2022-03-29 | Pridgen William | director | P | 600 | 4.94 | $2,964 |
| 2022-03-23 | Pridgen William | director | P | 2,197 | 5.46 | $12,002 |
| 2022-01-27 | Pridgen William | director | P | 4,180 | 5.98 | $24,998 |
| 2022-01-07 | De La Rosa Abel | director | P | 4,000 | 5.9 | $23,584 |
| 2022-01-06 | Whitley Richard James | director | P | 1,800 | 5.72 | $10,296 |
| 2022-01-04 | Keefer David R | director | P | 5,000 | 5.8 | $28,975 |
| 2022-01-04 | Thomas John C | director | P | 1,000 | 5.65 | $5,650 |
| 2022-01-03 | Pridgen William | director | P | 2,215 | 5.43 | $12,034 |
| 2021-12-23 | Whitley Richard James | director | P | 200 | 5.73 | $1,145 |
| 2021-12-21 | Pridgen William | director | P | 8,827 | 5.66 | $49,997 |
| 2021-12-21 | Duncan Gregory Scott | director | P | 5,000 | 5.52 | $27,615 |
| 2021-07-07 | Pridgen William | director | P | 942 | 6.32 | $5,951 |
| 2021-04-06 | Duncan Gregory Scott | director | P | 382 | 6.36 | $2,429 |
| 2021-04-05 | Duncan Gregory Scott | director | P | 15,675 | 6.17 | $96,757 |
| 2021-04-05 | Duncan Gregory Scott | director | P | 15,675 | 6.17 | $96,757 |
| 2021-01-29 | Pridgen William | director | P | 3,500 | 7.47 | $26,145 |
| 2021-01-28 | Walsh Angela | officer | P | 1,000 | 7.3 | $7,300 |
| 2021-01-28 | Pridgen William | director | M | 801 | 7.8 | $6,248 |
| 2021-01-28 | Keefer David R | director | M | 1,602 | 7.8 | $12,496 |
| 2021-01-06 | Duncan Gregory Scott | director | M | 801 | 7.8 | $6,248 |
| 2020-12-17 | Pridgen William | director | P | 1,500 | 11.98 | $17,970 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-10-30 S-3
- 2026-10-27 SCHEDULE 13D/A
- 2026-10-27 4
- 2026-10-21 SCHEDULE 13D/A
- 2026-10-19 8-K
- 2026-08-14 10-Q
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-13 8-K
- 2026-06-17 8-K
- 2026-06-17 4
- 2026-06-17 4
- 2026-06-17 4
- 2026-06-17 4
- 2026-05-15 SCHEDULE 13G
- 2026-05-15 10-Q
- 2026-05-14 8-K
- 2026-04-27 ARS
- 2026-04-27 DEF 14A
- 2026-04-17 PRE 14A
- 2026-03-26 8-K